Skip to main content

People in the News: William Welch, Dirk van den Boom, Ron Lindsay, Frederic Walder

Premium

Sequenom has promoted several members of its management team. William Welch is now the president and chief operating officer. He was previously senior vice president of diagnostics and has overseen the commercial operations of the MaterniT21 Plus test. Dirk van den Boom has been appointed executive vice president of research and development and chief technology officer from his position of senior vice president of research and development, which he has held since 2010. He joined the company in 1998. Ron Lindsay is now executive vice president of strategic planning. He was previously the executive vice president of research and development.


Fluidigm has named Frederic Walder to serve as its chief operating officer. Walder has been chief business officer at Fluidigm since 2010. From 1992 to 2010, Walder held various senior executive posts at Thermo Fisher Scientific.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.